Collegium Pharmaceutical Inc banner

Intrinsic Value

The intrinsic value of Collegium Pharmaceutical Inc (354) under the Base Case is 57.85 EUR per share. Compared with the current market price of 22.6 EUR, the stock appears Undervalued by 61% .

The intrinsic value is the average of valuations using the DCF method and multiples.

Do our valuations actually work? See backtest results .

Intrinsic Value
€57.85
Undervaluation 61%
Intrinsic Value
Price €22.6
Alert me when Collegium Pharmaceutical Inc is below its intrinsic value
Today €46.28 · Already reached, the price is 51.2% below it

Collegium Pharmaceutical Inc is cheaper than usual. It was this cheap or cheaper on just 4% of days in the past 5 years.

Alternatives to Collegium Pharmaceutical Inc

Fundamental Analysis

What Collegium Pharmaceutical Does

Pharmaceuticals Health Care

Collegium Pharmaceutical makes prescription medicines for pain management and related conditions. Its main product portfolio centers on branded therapies that doctors prescribe to patients who need longer-lasting pain control, especially in settings where other treatments have not worked well or are not appropriate. The company focuses on a narrow set of medicines rather than a broad drug catalog.

Headquarters
United States of America US
Employees
423
IPO date
May 7, 2015
Read the full company overview
View Company Overview
Financials
Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Ownership

Collegium Pharmaceutical insiders are selling within their usual range

Insider trading · Last trade on May 18, 2026

Sold $3.9m 6 insiders
Bought $0 Nobody bought
Trades by date
Open insider trading

Continue Research

Decided on Collegium Pharmaceutical? Get an email when Collegium Pharmaceutical Inc reaches the price you’d buy at. Free with an account.

Other Collegium Pharmaceutical listings

What is the Intrinsic Value of one Collegium Pharmaceutical Inc stock?

The intrinsic value for Collegium Pharmaceutical Inc (354) under the Base Case is 57.85 EUR.

Is Collegium Pharmaceutical Inc stock undervalued or overvalued?

Compared with the current market price of 22.6 EUR, the stock appears Undervalued by 61% .

How reliable are our estimates? See how past valuations played out
Back to Top